Brand names
Infliximab brand names
5 brands in 1 markets
Infliximab is sold under 5 brand names in 1 markets in our register data, including Avsola, Inflectra, Remicade, Renflexis, Zymfentra. The table shows the market, marketing authorisation holder, strengths and forms for each brand, with the register it comes from.
| Brand | Market | Marketing authorisation holder | Strengths and forms | Source |
|---|---|---|---|---|
| Avsola | United States | Amgen | 100 mg/10 mLPowder for injection | US FDA NDC directoryChecked 12 November 2026 |
| Inflectra | United States | Pfizer Laboratories | 100 mg/10 mLPowder for injection | US FDA NDC directoryChecked 12 November 2026 |
| Remicade | United States | Janssen Biotech | 100 mg/10 mLPowder for injection | US FDA NDC directoryChecked 12 November 2026 |
| Renflexis | United States | Organon | 100 mgPowder for injection | US FDA NDC directoryChecked 12 November 2026 |
| Zymfentra | United States | Celltrion | 120 mg/mLInjection, Kit | US FDA NDC directoryChecked 12 November 2026 |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Infliximab for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.